Brain atrophy components

Biomarker

1 paper3 findings

  • In silico1

Associations

3

Disease progression

upin humans1

1 study
  1. Brain atrophy components predict disease progression in humans.

    “CCL‐NMF provided a richer representation and demonstrated improved predictive performance across various outcomes, including AD, cardiovascular disease markers, and disease progression”

    Humansbrainn = 48,949

    Dominant Trajectories of Aging‐related Brain Atrophy Identified in 48,949 Individuals via a coupled Cross‐sectional and Longitudinal Non‐negative Matrix Factorization

    AAIC 2025 abstract24 Dec 2025

Cognitive decline

upin humans1

1 study
  1. Brain atrophy components are associated with cognitive decline in humans.

    “CCL‐NMF identified seven distinct brain atrophy components associated with Alzheimer's disease (AD), cognitive decline, and cardiovascular risk factors.”

    Humansaging-related brain atrophybrainn = 48,949

    Dominant Trajectories of Aging‐related Brain Atrophy Identified in 48,949 Individuals via a coupled Cross‐sectional and Longitudinal Non‐negative Matrix Factorization

    AAIC 2025 abstract24 Dec 2025

Alzheimer's disease

upin humans1

1 study
  1. Brain atrophy components are associated with Alzheimer's disease in humans.

    “CCL‐NMF identified seven distinct brain atrophy components associated with Alzheimer's disease (AD), cognitive decline, and cardiovascular risk factors.”

    Humansaging-related brain atrophybrainn = 48,949

    Dominant Trajectories of Aging‐related Brain Atrophy Identified in 48,949 Individuals via a coupled Cross‐sectional and Longitudinal Non‐negative Matrix Factorization

    AAIC 2025 abstract24 Dec 2025

More on Alzheimer's disease

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months